New study results show a simple blood test to measure brain-specific proteins released after a person suffers a traumatic brain injury (TBI) can reliably predict both evidence of TBI on radiographic imaging and injury severity. The potential benefit of adding detection of glial fibrillary acidic protein breakdown products (GFAP-BDP) to clinical screening with computed tomography (CT) and magnetic resonance imaging (MRI) is described in an article published in Journal of Neurotrauma.

Two studies from Johns Hopkins Kimmel Cancer Center add to preliminary evidence that stereotactic body radiotherapy (SBRT) appears as safe and effective as standard radiation treatment for certain patients with pancreatic cancer whose tumors are advanced but have not spread.

In a study using functional magnetic resonance imaging (fMRI), Virginia Tech Carilion Research Institute scientists found our inherent risk-taking preferences affect how we view and act on information from other people. The brain scans showed that study participants increased their perceived value of a gamble after seeing other people take that gamble. The neural signals also predicted the likelihood that participants would conform to others' choices.

Shimadzu Medical Systems USA announced the first U.S. West Coast installation of its Trinias C-12 high performance “crossover” system at Kalispell Regional Medical Center in Kalispell, Montana. Shimadzu dealer/partner Core Medical Imaging Inc. of Kenmore, Washington, completed the installation of the angiographic system, which went into operation at the medical center in late April.

Parents of patients treated at Children’s Hospital Los Angeles (CHLA) can now download a free app called ImageInbox on their smartphones to receive imaging files or to request the files be sent directly to another caregiver. CHLA is the first clinical site to offer the app, which is now available for free to any patient.

Fortis mitral transcatheter heart valve

MEDraysintell, proton therapy, world market, third edition, $1 billion, 2019

For the first time the proton therapy world market is anticipated to reach $1 billion in 2019, according to the third edition of the World Proton Therapy report from MEDraysintell. According to the report, almost 330 proton therapy treatment rooms will be available to patients, a jump from the 141 proton therapy treatment rooms operational in 2014 worldwide. However, by 2019 only 1 percent of the population that requires some sort of radiotherapy will be able to get a proton therapy treatment.

A new service called MyChoiceMD is preparing to launch in Colorado that aims to revolutionize the way patients find, pay for, schedule and track their routine medical care. The service has been incubating in Northern Colorado and has completed a 10-month pilot in Cheyenne under the name Galen. It is targeted at the large population of self-pay patients that includes both insured and uninsured patients.

Mount Sinai (New York) is expanding its use of an image-guided technology that focuses on removing only cancerous tissue in the prostate, sparing the rest of the gland. The technique presents a contrast to traditional approaches, where removing the entire prostate leaves patients safe from cancer, but facing profound sexual and urinary side effects.

In Africa, cancer kills more people than HIV/AIDS, malaria and tuberculosis combined. Approximately 40 percent of cancer cases can be prevented, and 40 percent can be cured with the right treatment. Together with Elekta, ministries of health in almost a dozen African nations are now working to build up their radiation therapy infrastructures and save lives.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now